MICA and neoplasm: Despite the overall clinical benefit regarding GvL/GvT effect without GvHD, adoptive NK cell therapies are hampered by tumor immune escape mechanism, such as blocking of NKG2D by soluble MICA (124), exhaustion of NK cells in the immune-suppressive tumor microenvironment (125) and limited persistence of NK cells.